Chinese General Practice ›› 2023, Vol. 26 ›› Issue (17): 2102-2107.DOI: 10.12114/j.issn.1007-9572.2022.0825
• Original Research • Previous Articles Next Articles
Received:
2022-08-08
Revised:
2022-12-20
Published:
2023-06-15
Online:
2022-12-20
Contact:
WU Xiaoke
通讯作者:
吴效科
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0825
组别 | 例数 | 年龄(岁) | BMI 〔M(QR),kg/m2〕 | WC 〔M(QR),cm〕 | WHR | 收缩压(mm Hg) | 舒张压(mm Hg) | AMH 〔M(QR),μg/L〕 | FSH (U/L) |
---|---|---|---|---|---|---|---|---|---|
IR(-)组 | 339 | 27.6±3.1 | 21.1(2.5) | 78(9) | 0.84±0.07 | 110±10 | 73±8 | 12.83(8.94) | 6.19±1.61 |
IR(+)组 | 114 | 28.2±3.4 | 22.2(2.3) | 82(9) | 0.86±0.06 | 112±8 | 74±7 | 10.93(7.80) | 6.12±1.89 |
t(Z)值 | -1.738 | 2.550a | 2.350a | -2.443 | -2.457 | -0.380 | 1.620a | 0.406 | |
P值 | 0.083 | <0.001 | <0.001 | 0.005 | 0.014 | 0.704 | 0.010 | 0.685 | |
组别 | LH 〔M(QR),U/L〕 | TT (nmol/L) | FT (ng/L) | SHBG 〔M(QR),nmol/L〕 | FAI 〔M(QR)〕 | FPG (mmol/L) | FINS 〔M(QR),pmol/L〕 | TC (mmol/L) | TG 〔M(QR),mmol/L〕 |
IR(-)组 | 11.28(9.47) | 1.64±0.62 | 2.20±0.86 | 47.10(34.07) | 3.26(3.63) | 4.78±0.81 | 47.89(31.04) | 4.56±0.94 | 1.06(0.63) |
IR(+)组 | 9.92(7.45) | 1.68±0.74 | 2.17±0.85 | 33.40(30.80) | 4.79(4.94) | 5.44±0.74 | 107.70(56.69) | 4.90±1.18 | 1.54(1.21) |
t(Z)值 | 1.150a | -0.547 | 0.331 | 2.500a | 1.953a | -7.720 | -9.558a | -2.827 | 3.088a |
P值 | 0.142 | 0.585 | 0.741 | <0.001 | 0.001 | <0.001 | <0.001 | 0.005 | <0.001 |
组别 | HDL-C (mmol/L) | LDL-C (mmol/L) | ApoA1 (g/L) | ApoB (g/L) | ALT 〔M(QR),U/L〕 | AST 〔M(QR),U/L〕 | TBiL 〔M(QR),μmol/L〕 | DBiL 〔M(QR),μmol/L〕 | 总胆汁酸〔M(QR),μmol/L〕 |
IR(-)组 | 1.37±0.35 | 2.81±0.77 | 1.53±0.30 | 0.80±0.21 | 6.00(4.25) | 11.00(5.00) | 6.30(3.60) | 2.40(1.70) | 1.40(1.80) |
IR(+)组 | 1.32±0.35 | 3.02±0.92 | 1.60±0.32 | 0.93±0.31 | 6.00(5.00) | 10.00(5.00) | 5.10(3.15) | 1.70(1.55) | 1.30(2.55) |
t(Z)值 | 1.312 | -2.131 | -1.866 | -4.111 | 0.569a | 1.092a | 2.360a | 2.210a | 1.034a |
P值 | 0.190 | 0.035 | 0.063 | <0.001 | 0.903 | 0.184 | <0.001 | <0.001 | 0.235 |
组别 | 尿素〔M(QR),μmol/L〕 | 肌酐〔M(QR),μmol/L〕 | 血β2微球蛋白(mg/L) | 钙(mmol/L) | 磷(mmol/L) | 镁(mmol/L) | 钠〔M(QR),mmol/L〕 | 钾(mmol/L) | 氯〔M(QR),mmol/L〕 |
IR(-)组 | 4.23(1.44) | 42.50(14.88) | 1.32±0.40 | 1.97±0.40 | 1.13±0.26 | 0.88±0.16 | 137.00(14.00) | 4.15±0.85 | 94.00(11.00) |
IR(+)组 | 4.06(1.60) | 38.75(13.22) | 1.20±0.37 | 1.87±0.43 | 1.07±0.24 | 0.83±0.17 | 133.50(17.74) | 4.11±0.97 | 92.00(12.25) |
t(Z)值 | 0.685a | 1.603a | 2.746 | 2.266 | 2.342 | 2.464 | 1.571a | 0.444 | 1.519a |
P值 | 0.736 | 0.012 | 0.006 | 0.024 | 0.020 | 0.014 | 0.014 | 0.657 | 0.020 |
Table 1 Differences in anthropometric and biochemical indicators between two groups
组别 | 例数 | 年龄(岁) | BMI 〔M(QR),kg/m2〕 | WC 〔M(QR),cm〕 | WHR | 收缩压(mm Hg) | 舒张压(mm Hg) | AMH 〔M(QR),μg/L〕 | FSH (U/L) |
---|---|---|---|---|---|---|---|---|---|
IR(-)组 | 339 | 27.6±3.1 | 21.1(2.5) | 78(9) | 0.84±0.07 | 110±10 | 73±8 | 12.83(8.94) | 6.19±1.61 |
IR(+)组 | 114 | 28.2±3.4 | 22.2(2.3) | 82(9) | 0.86±0.06 | 112±8 | 74±7 | 10.93(7.80) | 6.12±1.89 |
t(Z)值 | -1.738 | 2.550a | 2.350a | -2.443 | -2.457 | -0.380 | 1.620a | 0.406 | |
P值 | 0.083 | <0.001 | <0.001 | 0.005 | 0.014 | 0.704 | 0.010 | 0.685 | |
组别 | LH 〔M(QR),U/L〕 | TT (nmol/L) | FT (ng/L) | SHBG 〔M(QR),nmol/L〕 | FAI 〔M(QR)〕 | FPG (mmol/L) | FINS 〔M(QR),pmol/L〕 | TC (mmol/L) | TG 〔M(QR),mmol/L〕 |
IR(-)组 | 11.28(9.47) | 1.64±0.62 | 2.20±0.86 | 47.10(34.07) | 3.26(3.63) | 4.78±0.81 | 47.89(31.04) | 4.56±0.94 | 1.06(0.63) |
IR(+)组 | 9.92(7.45) | 1.68±0.74 | 2.17±0.85 | 33.40(30.80) | 4.79(4.94) | 5.44±0.74 | 107.70(56.69) | 4.90±1.18 | 1.54(1.21) |
t(Z)值 | 1.150a | -0.547 | 0.331 | 2.500a | 1.953a | -7.720 | -9.558a | -2.827 | 3.088a |
P值 | 0.142 | 0.585 | 0.741 | <0.001 | 0.001 | <0.001 | <0.001 | 0.005 | <0.001 |
组别 | HDL-C (mmol/L) | LDL-C (mmol/L) | ApoA1 (g/L) | ApoB (g/L) | ALT 〔M(QR),U/L〕 | AST 〔M(QR),U/L〕 | TBiL 〔M(QR),μmol/L〕 | DBiL 〔M(QR),μmol/L〕 | 总胆汁酸〔M(QR),μmol/L〕 |
IR(-)组 | 1.37±0.35 | 2.81±0.77 | 1.53±0.30 | 0.80±0.21 | 6.00(4.25) | 11.00(5.00) | 6.30(3.60) | 2.40(1.70) | 1.40(1.80) |
IR(+)组 | 1.32±0.35 | 3.02±0.92 | 1.60±0.32 | 0.93±0.31 | 6.00(5.00) | 10.00(5.00) | 5.10(3.15) | 1.70(1.55) | 1.30(2.55) |
t(Z)值 | 1.312 | -2.131 | -1.866 | -4.111 | 0.569a | 1.092a | 2.360a | 2.210a | 1.034a |
P值 | 0.190 | 0.035 | 0.063 | <0.001 | 0.903 | 0.184 | <0.001 | <0.001 | 0.235 |
组别 | 尿素〔M(QR),μmol/L〕 | 肌酐〔M(QR),μmol/L〕 | 血β2微球蛋白(mg/L) | 钙(mmol/L) | 磷(mmol/L) | 镁(mmol/L) | 钠〔M(QR),mmol/L〕 | 钾(mmol/L) | 氯〔M(QR),mmol/L〕 |
IR(-)组 | 4.23(1.44) | 42.50(14.88) | 1.32±0.40 | 1.97±0.40 | 1.13±0.26 | 0.88±0.16 | 137.00(14.00) | 4.15±0.85 | 94.00(11.00) |
IR(+)组 | 4.06(1.60) | 38.75(13.22) | 1.20±0.37 | 1.87±0.43 | 1.07±0.24 | 0.83±0.17 | 133.50(17.74) | 4.11±0.97 | 92.00(12.25) |
t(Z)值 | 0.685a | 1.603a | 2.746 | 2.266 | 2.342 | 2.464 | 1.571a | 0.444 | 1.519a |
P值 | 0.736 | 0.012 | 0.006 | 0.024 | 0.020 | 0.014 | 0.014 | 0.657 | 0.020 |
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
BMI | 0.255 | 0.097 | 6.935 | 0.008 | 1.291(1.067,1.561) |
WC | 0.041 | 0.019 | 4.692 | 0.030 | 1.042(1.004,1.081) |
FAI | 0.088 | 0.034 | 6.740 | 0.009 | 1.092(1.022,1.167) |
TG | 0.643 | 0.156 | 16.957 | <0.001 | 1.902(1.401,2.583) |
AMH | -0.045 | 0.021 | 4.429 | 0.035 | 0.956(0.918,0.997) |
TBiL | -0.138 | 0.051 | 7.364 | 0.007 | 0.871(0.789,0.962) |
磷 | -1.566 | 0.580 | 7.299 | 0.007 | 0.209(0.067,0.651) |
Table 2 Multivariate Logistic regression analysis of factors affecting insulin resistance in polycystic ovary syndrome patients with normal body mass index
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
BMI | 0.255 | 0.097 | 6.935 | 0.008 | 1.291(1.067,1.561) |
WC | 0.041 | 0.019 | 4.692 | 0.030 | 1.042(1.004,1.081) |
FAI | 0.088 | 0.034 | 6.740 | 0.009 | 1.092(1.022,1.167) |
TG | 0.643 | 0.156 | 16.957 | <0.001 | 1.902(1.401,2.583) |
AMH | -0.045 | 0.021 | 4.429 | 0.035 | 0.956(0.918,0.997) |
TBiL | -0.138 | 0.051 | 7.364 | 0.007 | 0.871(0.789,0.962) |
磷 | -1.566 | 0.580 | 7.299 | 0.007 | 0.209(0.067,0.651) |
[1] |
|
[2] |
|
[3] |
杨冬梓,赵晓苗. 多囊卵巢综合征的多学科干预和长期管理[J]. 中华妇产科杂志,2015,50(11):810-813. DOI:10.3760/cma.j.issn.0529-567x.2015.11.003.
|
[4] |
|
[5] |
李剑虹,任泽萍,陈波,等. 成人超重和肥胖10年回顾性队列研究[J]. 中国慢性病预防与控制,2012,20(6):691-692. DOI:10.16386/j.cjpccd.issn.1004-6194.2012.06.035.
|
[6] |
Rotterdam Eshre/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod,2004,19(1):41-47. DOI:10.1093/humrep/deh098.
|
[7] |
|
[8] |
于婧璐,侯丽辉,孙淼,等. 正常体质量指数的多囊卵巢综合征与胰岛素抵抗相关的危险因素分析[J]. 国际生殖健康/计划生育杂志,2020,39(2):117-120. DOI:10.3969/j.issn.1674-1889.2020.02.007.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
程芙蓉,郑金秀,陈裕坤,等. 体质量指数正常多囊卵巢综合征患者胰岛素抵抗的临床特征及影响因素分析[J]. 中国医师进修杂志,2018,41(6):528-531. DOI:10.3760/cma.j.issn.1673-4904.2018.06.012.
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
刘莉,吴霞,邹国良,等. 代谢综合征患者血清胆红素水平与胰岛素抵抗的相关性分析[J]. 山东医药,2021,61(33):30-33. DOI:10.3969/j.issn.1002-266X.2021.33.007.
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[1] | LI Ziyue, FANG Jiawen, LIN Kaicheng. Analysis and Prediction of the Disease Burden of Type 2 Diabetes Attributable to High Body Mass Index in China from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1126-1133. |
[2] | LIU Yang, WANG Yu, CONG Jing, GONG Yi, HAN Buwei, WANG Kaiyue, ZHU Mengyi, ZHANG Bei, WU Xiaoke. Analysis of Factors Influencing Hyperlipidemia in Female Polycystic Ovary Syndrome Patients with Normal Body Mass Index [J]. Chinese General Practice, 2024, 27(06): 717-722. |
[3] | LI Yaping, LI Xia. Research Progress of Correlation and Underlying Mechanisms between Metabolic Syndrome and Alzheimer's Disease [J]. Chinese General Practice, 2024, 27(03): 268-272. |
[4] | CAI Guangyun, CAI Yanjun, WANG Libin, LIU Deyi, WEI Shishi, WANG Hong, TIAN Chaowei. The 5-year Survival of Elderly Hypertension and Diabetes Patients Combined with Dyslipidemia [J]. Chinese General Practice, 2024, 27(01): 91-97. |
[5] | LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424. |
[6] | HU Jiayu, REN Lijue, JIN Huanhuan, SUN Tingting, JIN Meina, ZHOU Xueli, WEI Cuiying. The Level of Adipokine Metrnl and Its Relationship with Inflammation and Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome [J]. Chinese General Practice, 2023, 26(30): 3748-3752. |
[7] | KONG Dexian, XING Yuling, SUN Wenwen, ZHANG Zhimin, ZHOU Fei, MA Huijuan. Correlation between Estimated Glucose Disposal Rate and Metabolism-associated Fatty Liver Disease in Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(26): 3252-3258. |
[8] | FENG Xiaoling, YIN Wenqing, WANG Ying, HOU Lihui. Correlation Analysis between Different Free Testosterone Index Levels and Clinical Characteristics of Patients with Polycystic Ovary Syndrome [J]. Chinese General Practice, 2023, 26(24): 3005-3009. |
[9] | YUAN Xianxian, WANG Jia, ZHANG Kexin, YANG Ruihua, ZHENG Wei, LI Guanghui. Association between Blood Lipid Levels and Macrosomia in Pregnant Women with Different Pre-pregnancy Body Mass Index [J]. Chinese General Practice, 2023, 26(24): 2973-2979. |
[10] | ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming. The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [J]. Chinese General Practice, 2023, 26(21): 2589-2596. |
[11] | GAO Zhe, DUAN Kaixin, LYU Xiuqin, MA Huijuan, ZHANG Zhimei, SONG Guangyao. Mechanism of Glucagon-like Peptide-1 Receptor Agonist Improving Liver Lipid Deposition in a Rat Model of Insulin Resistance Induced by High-fructose Diet [J]. Chinese General Practice, 2023, 26(21): 2639-2646. |
[12] | HUANG Zeyu, SU Lei, SANG Jianfeng, ZHAO Ru, HAN Chen, WANG Qian, GU Tianwei, BI Yan, ZHU Dalong, SHEN Shanmei. Clinical Characteristics and Risk Factors of Normocalcemic Primary Hyperparathyroidism [J]. Chinese General Practice, 2023, 26(11): 1369-1374. |
[13] | YUAN Lijun, WEI Wenjing, ZHANG Xia, FU Ruiyuan, CHEN Qiu. Bariatric Surgery Increases the Risk of Fracture: a Meta-analysis [J]. Chinese General Practice, 2023, 26(11): 1382-1388. |
[14] | QIAN Fangfang, CAI Zhensheng, GU Tian, LI Haoxiang, ZHAO Li, YANG Ling, DENG Xia, YUAN Guoyue. Relationship between Ectodysplasin A and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(08): 911-916. |
[15] | TANG Zixuan, LI Jing, HUANG Qi, ZHANG Ying, ZHANG Han, WANG Qian, ZHANG Lin, CHENG Yao, LIAO Xin. Correlation between Adiponectin and Free Testosterone Index and Insulin Resistance in Patients with Polycystic Ovary Syndrome [J]. Chinese General Practice, 2023, 26(08): 927-932. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||